NewEdge Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.34M | Buy |
91,007
+1,286
| +1% | +$113K | 0.02% | 567 |
|
|
2026
Q1 | $7.65M | Sell |
89,721
-19,755
| -18% | -$1.76M | 0.03% | 535 |
|
|
2025
Q4 | $8.65M | Sell |
109,476
-444,191
| -80% | -$34.8M | 0.03% | 480 |
|
|
2025
Q3 | $44.3M | Buy |
553,667
+52,255
| +10% | +$4.46M | 0.2% | 99 |
|
|
2025
Q2 | $45.6M | Buy |
501,412
+27,749
| +6% | +$2.53M | 0.24% | 90 |
|
|
2025
Q1 | $44.4M | Buy |
473,663
+58,495
| +14% | +$5.24M | 0.26% | 84 |
|
|
2024
Q4 | $37.7M | Buy |
415,168
+344,845
| +490% | +$32.9M | 0.23% | 92 |
|
|
2024
Q3 | $7.3M | Buy |
70,323
+18,948
| +37% | +$1.93M | 0.05% | 362 |
|
|
2024
Q2 | $4.99M | Buy |
51,375
+5,363
| +12% | +$495K | 0.04% | 447 |
|
|
2024
Q1 | $4.14M | Sell |
46,012
-2,230
| -5% | -$189K | 0.04% | 445 |
|
|
2023
Q4 | $3.88M | Buy |
48,242
+2,246
| +5% | +$169K | 0.04% | 426 |
|
|
2023
Q3 | $3.27M | Sell |
45,996
-2,537
| -5% | -$190K | 0.04% | 435 |
|
|
2023
Q2 | $3.74M | Buy |
48,533
+3,030
| +7% | +$235K | 0.04% | 392 |
|
|
2023
Q1 | $3.44M | Buy |
45,503
+15,380
| +51% | +$1.14M | 0.04% | 384 |
|
|
2022
Q4 | $1.12M | Buy |
30,123
+951
| +3% | +$71.3K | 0.03% | 477 |
|
|
2022
Q3 | $2.05M | Sell |
29,172
-180
| -0.6% | -$14.1K | 0.03% | 425 |
|
|
2022
Q2 | $2.35M | Buy |
29,352
+4,329
| +17% | +$339K | 0.04% | 398 |
|
|
2022
Q1 | $1.9M | Sell |
25,023
-9,005
| -26% | -$713K | 0.03% | 437 |
|
|
2021
Q4 | $2.9M | Buy |
34,028
+18,488
| +119% | +$1.44M | 0.04% | 352 |
|
|
2021
Q3 | $1.17M | Sell |
15,540
-985
| -6% | -$78.2K | 0.03% | 471 |
|
|
2021
Q2 | $1.34M | Sell |
16,525
-3,120
| -16% | -$255K | 0.04% | 406 |
|
|
2021
Q1 | $1.55M | Buy |
19,645
+4,718
| +32% | +$370K | 0.05% | 340 |
|
|
2020
Q4 | $1.28M | Buy |
14,927
+897
| +6% | +$74.2K | 0.04% | 355 |
|
|
2020
Q3 | $1.08M | Sell |
14,030
-7,413
| -35% | -$565K | 0.04% | 365 |
|
|
2020
Q2 | $1.57M | Buy |
21,443
+7,913
| +58% | +$562K | 0.06% | 258 |
|
|
2020
Q1 | $898K | Sell |
13,530
-15,526
| -53% | -$1.09M | 0.04% | 331 |
|
|
2019
Q4 | $2M | Sell |
29,056
-2,502
| -8% | -$171K | 0.08% | 244 |
|
|
2019
Q3 | $2.2M | Buy |
31,558
+22,299
| +241% | +$1.62M | 0.1% | 202 |
|
|
2019
Q2 | $664K | Buy |
9,259
+1,386
| +18% | +$98.4K | 0.04% | 344 |
|
|
2019
Q1 | $540K | Buy |
7,873
+3,738
| +90% | +$241K | 0.03% | 378 |
|
|
2018
Q4 | $246 | Sell |
4,135
-4,374
| -51% | -$274K | 0.02% | 537 |
|
|
2018
Q3 | $570K | Sell |
8,509
-2,006
| -19% | -$134K | 0.04% | 328 |
|
|
2018
Q2 | $679 | Buy |
10,515
+327
| +3% | +$21.4K | 0.06% | 262 |
|
|
2018
Q1 | $715K | Buy |
10,188
+1,485
| +17% | +$107K | 0.08% | 227 |
|
|
2017
Q4 | $657K | Sell |
8,703
-92
| -1% | -$6.72K | 0.09% | 205 |
|
|
2017
Q3 | $636K | Sell |
8,795
-78
| -0.9% | -$5.62K | 0.1% | 189 |
|
|
2017
Q2 | $648K | Buy |
8,873
+4,143
| +88% | +$308K | 0.11% | 170 |
|
|
2017
Q1 | $347K | Sell |
4,730
-5,449
| -54% | -$381K | 0.08% | 189 |
|
|
2016
Q4 | $668K | Buy |
+10,179
| New | +$698K | 0.19% | 119 |
|
Other funds holding CL
VCM
VPM
NewEdge Advisors's CL Position: Q2 2026 in Review
NewEdge Advisors increased its Colgate-Palmolive (CL) stake by 1.4% in Q2 2026, buying an estimated $113K and bringing the position to 91,007 shares worth $8.34M. The position accounts for 0.02% of the portfolio, ranked #567.
NewEdge Advisors first reported a position in CL in Q4 2016 and has held it in 39 quarters since. The position peaked at $45.6M in Q2 2025. 1,704 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- NewEdge Advisors held 91,007 shares of Colgate-Palmolive worth $8.34M as of Q2 2026.
- NewEdge Advisors bought 1,286 Colgate-Palmolive shares in Q2 2026, an estimated $113K.
- Colgate-Palmolive made up 0.02% of NewEdge Advisors's portfolio in Q2 2026, its #567 holding.
- NewEdge Advisors first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 39 quarters since.
- NewEdge Advisors's Colgate-Palmolive position peaked at $45.6M in Q2 2025.
- 1,704 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.